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Dr. Hyeyoon Chang : Department of pathology, Korea 
University Medical Center, Guro Hospital, Seoul, Korea
“BRAFV600E Mutation Analysis of Liquid Based 
Preparation-Processed Fine-Needle Aspiration 
Sample Improves the Diagnostic Rate of Papillary 
Thyroid Carcinoma”
?? : Introduction Early detection and diagnosis of papil-
lary thyroid carcinoma ?PTC? are important in the manage-
ment of patients. Liquid-based preparation ?LBP, Thinprep®? 
of fine needle aspiration from thyroid nodules has been widely 
used and is replacing the conventional smear, because residual 
samples can be used for ancillary tests. Detection of the 
BRAFV600E mutation in cytology specimens could aid in the 
diagnosis of PTCs. We analyzed the cytologic features and 
BRAFV600E mutation status using thyroid LBP-FNA samples.?
Materials & Methods A total of 191 histologically confirmed 
thyroid LBP-FNA specimens were selected. We analyzed 
cytomorpholoigic features and BRAFV600E mutation status in 
both LBP-FNA samples and the corresponding formalin-fixed 
paraffin-embedded tissues. The Seeplex® BRAF ACE detec-
tion kit, melting curve analysis ?MCA? with SYBR green and 
sequencing analysis were used to detect BRAFV600E mutations.?
Results In 191 patients, 126 had histologically confirmed 
PTCs, and 65 were benign lesions and carcinomas of other 
types. In tissue samples of PTCs, the BRAFV600E mutation 
was detected in 71 ?56.3%? using BRAF kit, 96 ?76.2%? cases 
using MCA and 82 ?65.1%? using sequencing analysis. Using 
residual cytologic material, the BRAFV600E mutation was 
detected in 93 ?73.8%? patients using the BRAF kit, 96 
?76.2%? patients using MCA and in 92 ?73.0%? using 
sequencing analysis in histologically confirmed PTC. Using 
LBP cytology alone, the sensitivity for diagnosis of PTC was 
71.4%. When BRAFV600E mutation analysis was done in con-
junction with cytologic diagnosis, the diagnostic sensitivity for 
detecting PTC was increased to 84.9% ?BRAF kit, MCA, and 
sequencing analysis, respectively?. Conclusions We used 
three methods for detecting BRAFV600E mutation using residual 
materials after cytomorphological examination and there were 
no significant differences between each method. And 
BRAFV600E mutation analysis using residual LBP cytological 
samples may be a useful additional diagnostic tool for diagnosis 
of PTC.
Keywords : Liquid based preparation of cytology, 
BRAF, Thyroid, Papillary carcinoma
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Dr. Kais Kasem : Griffith University School of 
Medicine
“JK-1 gene. A new potential tumour suppressor 
gene in colorectal cancer”
?? : Previous studies on oesophageal squamous cell car-
cinoma have led to the discovery of a new gene ?JK-
1{FAM134B}? that plays a role in cancer pathogenesis. JK-1
?FAM134B?, a novel gene located at 5p15.2, was found to be 
over-expressed in oesophageal squamous cell carcinoma cell 
lines and patient cases. Overexpression of JK-1 in NIH-3T3 
mouse fibroblasts and HEK293 cells caused an increase in 
growth rate, colony formation in soft agar and foci formation in 
confluent cultures. Also, high-grade sarcomas were formed 
in athymic nude mice following subcutaneous injection of JK-
1-overexpressing NIH-3T3 cells. Apart from this study, the 
molecular features, function and potential role in human can-
cer of this gene remained largely unknown.
This is the first systematic study to address JK-1 
?FAM134B? expression, copy number and mutations on a 
model of colorectal cancer. A large cohort of cases ?236 
colorectal cancers, 32 colon adenomas and 20 colonic non 
tumour tissue samples? were recruited for the study. JK-1 
?FAM134B? was quantified at DNA, mRNA and protein levels, 
using paraffin embedded tissue and colorectal cell lines to 
understand its role in tumour development. Moreover, a suc-
cessful knock down of JK-1 ?FAM134B? protein was per-
formed using shRNA lentiviral particles and its downstream 
effects were studied in human colon cancer cell lines.
Changes in JK-1 ?FAM134B? DNA copy number were asso-
ciated with tumour recurrence, histological subtypes, and can-
cer stage. Lower copy numbers were associated with higher 
T ?p=0.013?, N ?p=0.05? and overall stage of cancer
?p=0.042?. Conversely, higher DNA copy numbers were 
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detected more often in the mucinous type of colorectal cancer
?p=0.001?.
JK-1 ?FAM134B? expression profile at mRNA and protein 
level was investigated in colorectal cancer and adenoma 
patients using real-time quantification PCR and immunohisto-
chemistry. In all colorectal tissues, JK-1 ?FAM134B? mRNA 
was expressed, though with noticeable variation. Adenomas 
showed a much higher rate of mRNA expression, whilst can-
cer’s levels of expression were significantly lower ?p=0.005?.?
Within the colorectal cancer population, significantly lower 
mRNA expression was noted in higher T, N, M and overall 
stages ?p=0.039?.
In concert with the changes seen on the mRNA level, JK-1
?FAM134B? protein expression was lower in colorectal can-
cers of larger size ?p=0.004? and higher stage ?p=0.005?.
The functional role of JK-1 ?FAM134B? in human cancer 
was studied in vitro, using shRNA-lentiviral based knock down 
methods in SW480 cell line. JK-1 ?FAM134B? suppression 
in a colon cancer cell line resulted in increased cell invasive-
ness and migration capacity on multiple extracellular matrix 
substrates ?p=0.04?. It had no effect, however, on cancer 
cellular proliferation, as shown in a MTT calorimetric assay.
This study noted multiple new findings, including relation-
ships with clinical and pathological parameters with JK-1 
?FAM134B? copy number, mRNA and protein expressions in 
colorecta l  cancer.  The f indings suggest  that  JK-1 
?FAM134B? gene and its products can be a potential new 
tumour suppressor gene. This study also noted functional 
roles of JK-1 ?FAM134B? in cell invasion and migration capac-
ity in colorectal cancer. Results of this study indicate that 
JK-1 ?FAM134B? has a significant role in human cancer 
pathogenesis and is likely to be involved in the development 
and progression of colorectal cancer and is linked to cancer ini-
tiation, invasiveness, aggressiveness and metastasis.
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Prof. Dr. José F. Rodríguez-Vázquez : Dpto.de 
Anatomía y Embriología Humana II, Facultad de Medic-
ina, Universidad Complutense
“The development of the stapes and the under-
standing of the variations from embryology”
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Dr. Rasmani Hazra : Andrology Laboratory, University 
of Sydney, ANZAC Research Institute
“Optimal timing of the temporal expression of Ser-
toli cell androgen receptor is critical in spermato-
genesis and male fertility”
?? : Androgen actions are essential for the initial comple-
tion and then maintenance of spermatogenesis. Complete 
androgen deficiency or loss of functional androgen receptor 
?AR? causes spermatogenic arrest and infertility. However, 
male germ cells in human and rodent postnatal testes lack 
functional AR expression and mouse AR-deficient germ cells 
develop normally, demonstrating the importance of the local 
AR-expressing somatic Leydig, peritubular and Sertoli cell 
populations. Sertoli cells play a crucial role in fetal gonadal 
development and postnatal spermatogenesis, and ultimate 
total testicular Sertoli cell number at maturity is a major 
determinant of final germ cell numbers in mature testes.?
Sertoli cells display distinctive dynamic changes in AR expres-
sion levels during postnatal development, and between sper-
matogenic stages in mature testes, unlike constant AR 
expression in developing and adult Leydig and peritubular cell 
types. Therefore, the ontogenic development of Sertoli cell 
AR expression suggests that androgen sensitivity is acquired 
in an orchestrated manner in defined stages of postnatal and 
adult spermatogenic development. Recently, we created a 
unique transgenic ?Tg? mouse model to determine the tempo-
ral role of Sertoli cell ?SC? AR expression in spermatogenic 
development. The Tg SC-specific rat Abp promoter directs 
human AR ?TgSCAR? expression, providing strong premature 
postnatal AR immunolocalized to SC nuclei, and induces pre-
cocious spermatogenic development. Independent TgSCAR 
lines revealed dose-dependent AR actions during testicular 
development. TgSCAR elevated postnatal expression of SC 
androgen-regulated genes ?Rhox5, Eppin, Cldn11?, acceler-
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ated seminiferous tubular lumen formation and meiotic-post-
meiotic germ cell development. TgSCAR accelerated Leydig 
cell differentiation, shown by elevated mature/immature Ley-
dig cell number ratios in TgSCAR versus wildtype testes.?
Equivalent reductions in total testicular Sertoli and Leydig cell 
numbers maintained normal Sertoli : Leydig cell ratios in 
pubertal-adult TgSCAR mice, suggesting SCAR control of tes-
ticular Leydig cell capacity. Serum and intratesticular testos-
terone, DHT and its 3α and 3β-diols levels, and seminal 
vesicle weights were normal in adult TgSCAR mice. Total 
intratesticular testosterone and DHT/Leydig cell were 
increased in adult TgSCAR versus wildtype testes, indicating 
elevated steroidogenic capacity.
TgSCAR reduced adult testes size and SC population 
whereas circulating FSH and testosterone levels were main-
tained. Comparison of total testicular germ cell populations 
demonstrated normal spermatogonia : Sertoli ratios and ele-
vated spermatocyte : SC ratios in TgSCAR mice, indicating 
predominant SCAR-mediated control of meiotic development.?
In contrast, postmeiotic spermatid : SC ratios declined below 
normal. Despite smaller testes and reduced postmeiotic 
development, heterozygous TgSCAR males remained fertile.?
However, preliminary analysis of homozygous TgSCAR mouse 
has revealed subfertile / infertile males exhibiting testes 
35-40% of normal size and a further reduction in SC numbers 
despite normal levels of circulating testosterone and FSH.?
These homozygous testes showed various spermatogenic 
defects, some with advanced germ cells and some devoid of 
germ cells with vacuolisation and Sertoli cell only phenotype.?
Furthermore, extensive stage-dependent germ cell apoptosis 
?TUNEL assay? was observed in homozygous compared to 
heterozygous and wildtype mice, suggesting excessive AR 
compromised germ cell quality. Therefore, our unique TgS-
CAR gain-of-function model shows, for the first time, a vital 
role for stringent temporal regulation of SC-specific AR for 
optimal spermatogenic development and male fertility.
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Prof. Bronwyn A. Kingwell : Baker IDI Heart and 
Diabetes Institute, Melbourne Australia
“ACE Inhibition and Peripheral Artery Disease : 
New Implications for Intermittent Claudication”
?? : Peripheral artery disease affects 202 million people 
worldwide and is currently under-diagnosed and under-
treated, despite the 30% 5 year mortality rate associated with 
this condition.1? In addition to these serious consequences, 
quality of life is reduced due principally to impaired mobility in 
the one third of PAD patients experiencing intermittent clau-
dication. Current medical therapies to improve walking abil-
ity have low efficacy.  Building on our pilot study from 2006 
?n=40?,2? we have recently demonstrated that 24 weeks ther-
apy with ramipril improves walking ability by a magnitude 
which is more than five fold greater than currently indicated 
therapies ?n=212?.3? The physical functioning aspects of 
quality of life were also substantially improved.3? While vaso-
dilatation is an expected mechanism associated with ACE inhi-
bition, exploratory investigations implicate arteriogenesis/
angiogenesis and reduction in inflammatory, thrombotic and 
leukocyte adhesion processes amongst additional actions of 
ramipril which may contribute to improved leg perfusion and 
walking ability.4? Of these, the largest effects were with 
respect to increases in circulating arteriogenic/angiogenic 
markers ?VEGF-A and FGF? suggesting that ramipril may 
contribute to growth of new blood vessels. This assertion 
will require further substantiation in future animal and clinical 
studies.
Clinical Perspective : An increase in mobility and physi-
cal activity not only has immediate implications for improved 
quality of life, but would be expected to have beneficial conse-
quences for atherosclerotic vascular disease in other territo-
ries including the coronaries. Effective management of PAD 
and claudication should therefore be an important goal in the 
prevention and management of coronary and cerebral vascular 
disease. Ramipril is off patent and represents an effective 
and inexpensive agent which has dual benefits on walking abil-
ity1? and cardiovascular outcomes.5?
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James Douglas Engel : University of Michigan Medical 
School
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Irene Tracey Ph.D. : Oxford Centre for Functional 
Magnetic Resonance Imaging of the Brain ?FMRIB? & 
Nuffield Division Anaesthetics, Nuffield Department 
Clinical Neurosciences, University of Oxford, England 
UK
“Why Image Pain ?”
?? : The past decade has seen a rapid increase in the 
number of papers published in the area of ‘pain imaging’.?
Many techniques are now available to explore the human cen-
tral nervous system from a functional, structural and chemical 
perspective in both patients and healthy subjects. Relating 
specific neurophysiologic measures to perceptual or non-per-
ceptual changes induced by peripheral or central sensitisation, 
behavioural, psychological or pharmacological mechanisms and 
identifying their site of action within the CNS has both value 
and has been a major goal for scientists, clinicians and the 
pharmaceutical industry. Identifying non-invasively where 
functional and structural plasticity, sensitisation and other 
amplification or attenuation processes occur along the pain 
neuraxis for an individual and relating these neural mecha-
nisms to specific pain experiences, measures of pain relief, 
persistence of pain states, degree of injury and the subject’s 
underlying genetics, has neuroscientific relevance and poten-
tial diagnostic value.
With the advent of functional neuroimaging methods, such 
as Blood Oxygen Level Dependent ?BOLD? functional mag-
netic resonance imaging ?FMRI?, Arterial Spin Labelling 
?ASL? quantitative perfusion imaging, positron emission 
tomography ?PET?, electroencephalography and magnetoen-
cephalography this has been made feasible. These read-outs 
of varying physiological types are not simple surrogate mea-
sures of pain rating, but rather a complex and sophisticated 
non-invasive ‘behind the scenes’ neurophysiological read-out 
of nociceptive processing that underpins the subjective experi-
ence and can be powerfully used to aid explanation of a sub-
ject’s multidimensional pain experience. As the measures 
can be related to what the subject describes and what we can 
additionally measure about the subject ?psychological, person-
ality, physiological?, it enables us to disentangle for an individ-
ual how or whether factors like anxiety, depression, attention, 
central sensitization, etc., mechanistically might influence 
nociceptive processing at the brain level to alter the pain expe-
rience. It is my expectation that ‘pain neuroimaging’ will play 
an increasing role in pain neuroscience, clinical decision-mak-
ing and analgesic drug development in the coming decade.
??? : ?????
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Professor Jon M. Fukuto, PhD : Department of 
Chemistry, Sonoma State University, Sonoma CA, USA
“Redox Biology of Hydrogen Sulfide”
?? : The chemical biology of hydrogen sulfide has become 
a topic of etreme interest due to its newly discovered physio-
logical/biological actions. Currently, the mechanism?s? by 
which H2S mediates its biological functions remains obscure.?
Recently, persulfides ?RSSH? have been implicated as impor-
tant species in H2S biology. However, the intimate chemical 
properties and reactions of persulfides that may be important 
to its biology have not been fully elucidated. Thus, work in 
this lab has focused on the fundamental chemical biology of 
persulfides in order to determine what properties of persul-
fides may be important its biology. Studies on the reductive 
and nucleophilic chemistry of persulfides has been carried out.?
These and other studies regarding the stability of these elu-
sive species were discussed. ???????????? ??
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Prof. David J. Yang : The University of Texas MD 
Anderson Cancer Center, Department of Experimental 
Diagnostic Imaging
“Radionuclides for Theranostic Approaches in Can-
cers :  Imaging Guided Personalized Medicine for 
Treatable Diseases”
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Prof. Jianan Li : Center of Rehabilitation Medicine, 
Nanjing Medical University First Affiliated Hospital, 
Nanjing, China
“Walking and gait training : from early interven-
tion to long term strategy”
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Dr. Man-Ho Choi : Future Convergence Research Divi-
sion, Korea Institute of Science and Technology
“Recent advances in metabolic steroid signatures 
in Korea : technical briefs and biomedical applica-
tions”
?? : In contrast to immunoaffinity-based techniques that 
mainly focus on single enzymes or single metabolic reactions, 
the profiling analysis involves the collection of quantitative 
results for a broad series of metabolites to understand meta-
bolic dynamics associated with biological changes of interest. 
Profiling of urinary androgens is one of the establishing tech-
niques in doping analysis for detection of abused steroids of 
endogenous origin, especially testosterone and dehydroepian-
drosterone.
Due to abnormalities in steroidogenesis are responsible for 
the development of many endocrine diseases, gas chromatog-
raphy-mass spectrometry-based profiling methods have been 
extensively developed to elucidate altered expressions of 
whole steroid metabolism. The steroid-wide association 
?SWA? study in various biological specimens, such as urine, 
blood, and hair, allows “steroid signatures”, which can be visu-
alized using hierarchically clustered heat-maps. Altered con-
centrations of steroids may also reveal differences between 
the ratios of steroid precursors and their metabolites ?repre-
senting enzyme activity?. Although enzyme activities have 
been conventionally monitored by immunoassays, over-esti-
mation has limited these assays because of cross-reacting 
antibodies. Our SWA study focuses on explaining the activi-
ties of enzymes correlated with whole steroidogenesis for 
clinical diagnosis as well as mining biomarker in androgenic 
alopecia and hypertensive/lipid storage diseases.
As the alternative, individual quantification of steroids and 
their metabolic ratios combined with non-invasive biological 
samplings, including hair and blood spot on a paper, can be 
useful tools for screening of pathological conditions in clinical 
laboratories. Further study in establishing the reference val-
ues of both relative concentrations and metabolic ratios of vari-
ous steroid hormones from the methods are in progress.
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Suresh T. Chari : Mayo Clinic College of Medicine
“Early detection of pancreatic cancer : problems 
and prospects”
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Jean Bismuth, MD : DeBakey Heart & Vascular Cen-
ter, Houston Methodist Hospital
“The Methodist Experience with EVAR & TEVAR 
in Challenging Cases?What Exactly Is Radial 
Fit ??”
?? : Introduction : This article introduces the concept 
of radial fit-the optimization of force and conformability of a 
device in a disease and anatomy-specific manner. Ideally, we 
would like to see a device about the entire circumference of 
the aorta with enough radial force to provide a seal without 
adversely affecting the vessel wall with excessive force. In 
maintaining these elements, the device should be able to con-
form to non-uniform circumferential anatomies and a variety 
of longitudinal aortic shapes and be usable in a range of aortic 
pathologies with variable vessel wall characteristics. A 
device is only able to appose the wall along its entire surface if 
it has features that permit adaptability.
RADIAL FIT : EXPANDED OVERSIZING RANGE
A key example of a device’s adaptability is the expanded 
oversizing range of the Conformable GORE TAG Device 
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?Gore & Associated? which can accommodate a large treat-
ment range with a single device. In preoperative planning 
computed tomographic angiography is the most commonly 
used modality. As we gain significant experience in cardiac 
?dynamic? magnetic resonance imaging ?MRI? and electrocar-
diography-gated computed tomography, we realize that there 
can be up to 27.5% variation between systolic and diastolic 
aortic diameters. It is difficult to calculate the most appropri-
ate fit in preoperative imaging where dimensions are mea-
sured during diastole. In this case, radial fit is the ability of a 
stent graft to manage a range of diameters without losing 
radial apposition. These expanded treatment ranges are also 
important when considering tapered aortas, traumatic disrup-
tions in younger patients, and aortic coarctation, in which a 
difference of up to 9.5 m between the proximal and distal 
diameters can be accommodated with a tapered device.
RADIAL FIT : CONFORMABILITY
In preoperative measurements, we tend to identify tortuos-
ity and sharp angulations at the arch or diaphragm as caution-
ary landing zones generally trying to move that landing zone 
into straighter segments. Proper radial fit improves conform-
ability so that the device is able to seal in territory that was 
previously hostile because of tortuosity, including difficult 
landing zones distal to the left subclavian artery. There, 
radial fit has the potential of avoiding a significant percentage 
of left carotid-subclavian bypasses, which have become fairly 
standard wen coverage of the left subclavian artery is required.
In conclusion, device can impact outcomes of TEVAR based 
on radial fit.
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